Hematopoietic stem cell transplant (HSCT), autologous

Do Not Use

For the following indications, there is insufficient or no evidence to support the use of IG. Alternatives to IG are often available.

Recommendations

IG is not recommended for routine post-transplant care in autologous HSCT.

(see separate entry for secondary hypogammaglobulinemia)